May 21, 2021 ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development
May 19, 2021 ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors
May 12, 2021 ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, as Chair of Scientific Advisory Board
Mar 22, 2021 ProMIS Neurosciences Completes US$7M (CDN$8.75M) Financing with Distinguished Group of Boston Based Investors
Feb 2, 2021 ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid Field